Skip to main content
Fig. 1 | Diagnostic Pathology

Fig. 1

From: Influence of integrated molecular pathology test results on real-world management decisions for patients with pancreatic cysts: analysis of data from a national registry cohort

Fig. 1

Kaplan-Meier analysis of time-to-malignancy in a multivariate model as predicted by IMP and ICG. Y-axis represents probability of benign outcome in patients after initial IMP test. X-axis represents time post initial EUS-FNA that patient outcomes were determined based on review of follow-up medical records

Back to article page

Diagnostic Pathology

ISSN: 1746-1596

Contact us